Success requires AI that is customized, regulated, hybrid in its data structure and grounded at the deepest levels of the ...

Please give an overview of the recent compliance pressures that have been put on pharmaceutical companies. Compliance always has always been a high priority for data integrity in the pharmaceutical ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

With these innovations, Expert.ai continues to set the standard for applying AI in Pharma & Life Sciences, delivering greater ...

DUBLIN--(BUSINESS WIRE)--The "Efficient Batch Record Design and Review" training has been added to ResearchAndMarkets.com's offering. This online training is designed for professionals in the ...

Commerce minister Piyush Goyal had recently said that data exclusivity could help attract R&D investments in the pharmaceuticals sector. However, data exclusivity to originator firms could facilitate ...

Information gleaned from organized data is one of a pharmaceutical business's most valuable resources. The key word in this statement is "organized," as free-flowing data is significantly different ...

While pharma C-suite executives find themselves increasingly seduced by the promise of “digital transformation,” and especially by the idea of leveraging AI, the lived, on the ground reality within ...

Data content management will drive the growing global data and analytics market in the pharmaceutical sector, which will reach a valuation of $2.1bn by 2028, according to a report. The 2024 edition of ...

aTyr Pharma's pivotal data readouts in 2025 for SSc-ILD (Phase 2) and pulmonary sarcoidosis (Phase 3) could significantly impact its market potential and approval prospects. Efzofitimod shows promise ...

LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapies ...